FDA Links Childhood Deaths to Covid Vaccines: Internal Memo Raises Concerns

An internal memo from the Food and Drug Administration (FDA) has raised significant concerns regarding the safety of Covid vaccines, linking the deaths of at least 10 children to the vaccine. The memo, which was not publicly released but obtained by The New York Times, was authored by Dr. Vinay Prasad, the director of the FDA’s vaccine division. It outlines findings from a review of reports on childhood deaths, suggesting a connection to myocarditis, an inflammation of the heart muscle. However, the memo lacks critical details, including the ages of the children, any pre-existing health conditions, and the specific vaccines involved.

New York Times

The memo's release comes amid ongoing debates about vaccine safety, particularly concerning Covid-19 vaccinations. Health Secretary Robert F. Kennedy Jr. has been a vocal critic of the Covid vaccines, labeling them as dangerous despite the prevailing scientific consensus that they are safe. This internal document has intensified scrutiny over the FDA's regulatory practices and the transparency of vaccine safety data.

New York Times

The FDA has not publicly confirmed the findings of the memo, nor has it provided additional context regarding the reported deaths. Critics of the memo, including public health experts, have expressed skepticism about its conclusions, particularly given that the findings have not been published in a peer-reviewed medical journal. This lack of peer review raises questions about the validity of the claims made in the memo and the motivations behind its internal circulation.

New York Times

Health experts and vaccine advocates have criticized the memo for its lack of transparency and the potential to mislead the public regarding vaccine safety. They argue that the memo could contribute to vaccine hesitancy, undermining public health efforts to combat Covid-19. Critics emphasize that the scientific community overwhelmingly supports the safety and efficacy of vaccines, and any claims of danger should be substantiated with rigorous evidence.

New York Times

There is a notable absence of detailed information regarding the circumstances surrounding the reported deaths. The memo does not specify the ages of the children, their health histories, or the specific vaccines linked to the myocarditis cases. This lack of detail has led to conflicting interpretations of the data, with some viewing it as a legitimate concern and others dismissing it as unfounded alarmism.

New York Times

• “The findings have not been published in a peer-reviewed medical journal, drawing suspicion from some critics of Health Secretary Robert F.” — The New York Times

New York Times

• “He sent it to agency staff members on Friday, outlining findings from a review of reports concerning childhood deaths and attributing them to myocarditis, or inflammation of the heart muscle.” — Dr. Vinay Prasad, FDA

New York Times

The implications of the FDA's internal memo are significant, as they may influence public perception of vaccine safety and the regulatory landscape surrounding Covid vaccinations. Further investigation and transparency from the FDA will be crucial in addressing these concerns and restoring public trust in vaccination efforts.

New York Times